Medical & Vaccines

(READ) Pfizer recalls blood pressure drug Accupril after detecting high levels of a human carcinogen

Pfizer announced a nationwide recall of five lots of its blood pressure drug quinapril HCL (Accupril) after detecting unacceptable levels of nitrosamine, a human carcinogen. Read Pfizer’s official recall notification below: FOR IMMEDIATE RELEASE – NEW YORK, NY., April 22,2022 Pfizer is voluntarily

(READ) Pfizer recalls blood pressure drug Accupril after detecting high levels of a human carcinogen Read More »

(READ) Two dose Covid vaccines ‘not effective’ in preventing illness from Omicron

The following is an excerpt from Medscape. Study Synopsis: “The currently available 2-dose COVID-19 vaccines were not effective in preventing symptomatic disease caused by the omicron variant, as determined according to data from more than 800,000 omicron-infected individuals.” Clinical Context

(READ) Two dose Covid vaccines ‘not effective’ in preventing illness from Omicron Read More »

Scroll to Top